Hyperprogressive disease in advanced cancer patients with liver metastasis treated with PD-1 inhibitors: two case reports

Hyperprogressive disease (HPD) is a phenomenon defined as extremely rapid tumor progression within a short time following immunotherapy. To date, distinguishing which subgroups may be eligible for anti-PD-1/PD-L1 treatment has presented a clinical challenge. Moreover, no sufficiently convincing biom...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Zhuangbin, Liu, Qing, Wei, Qiongyin, Lin, Lan, Chen, Xiangqi, Xue, Dan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575996/
https://www.ncbi.nlm.nih.gov/pubmed/33145319
http://dx.doi.org/10.21037/atm-20-3928

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575996/
https://www.ncbi.nlm.nih.gov/pubmed/33145319
http://dx.doi.org/10.21037/atm-20-3928

Ejemplares similares